Cipla reports Profit after tax of Rs 10177.60 Mln, in the December 2023 quarter

22 Jan 2024 Evaluate
The revenue zoomed 23.92% to Rs. 43813.30 millions for the quarter ended December 2023 as compared to Rs. 35357.30 millions during the corresponding quarter last year.Net profit for the quarter ended December 2023 increased significantly by 70.30% to Rs. 10177.60 millions from Rs. 5976.20 millions.Operating profit for the quarter ended December 2023 rose to 15248.40 millions as compared to 9559.30 millions of corresponding quarter ended December 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 43813.30 35357.30 23.92 133642.40 115331.40 15.88 157906.00 153808.20 2.66
Other Income 1689.80 1271.20 32.93 5320.50 3370.80 57.84 4567.90 6667.00 -31.48
PBIDT 15248.40 9559.30 59.51 44717.20 32205.80 38.85 42493.70 43779.30 -2.94
Interest 90.60 56.60 60.07 171.70 153.70 11.71 270.20 269.30 0.33
PBDT 15157.80 9502.70 59.51 44545.50 32052.10 38.98 40364.50 43510.00 -7.23
Depreciation 1350.20 1299.60 3.89 4507.80 4343.30 3.79 5959.10 5466.20 9.02
PBT 13807.60 8203.10 68.32 40037.70 27708.80 44.49 34405.40 38043.80 -9.56
TAX 3630.00 2226.90 63.01 10613.00 7377.40 43.86 9710.10 9218.00 5.34
Deferred Tax 143.10 80.20 78.43 40.60 -15.10 -368.87 -400.90 -276.90 44.78
PAT 10177.60 5976.20 70.30 29424.70 20331.40 44.73 24695.30 28825.80 -14.33
Equity 1614.70 1614.30 0.02 1614.70 1614.30 0.02 1614.30 1613.60 0.04
PBIDTM(%) 34.80 27.04 28.73 33.46 27.92 19.82 26.91 28.46 -5.46

Cipla Share Price

1407.55 -1.85 (-0.13%)
29-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1521.95
Dr. Reddys Lab 6279.95
Cipla 1407.55
Zydus Lifesciences 963.50
Lupin 1640.30
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.